Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors ofTrypanosoma brucei
Open Access
- 29 September 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 58 (19) , 7695-7706
Abstract
There is an urgent need for new, brain penetrant small molecules that target the central nervous system second stage of human African trypanosomiasis (HAT). We report that a series of novel indoline-2-carboxamides have been identified as inhibitors of Trypanosoma brucei from screening of a focused protease library against Trypanosoma brucei brucei in culture. We describe the optimization and characterization of this series. Potent antiproliferative activity was observed. The series demonstrated excellent pharmacokinetic properties, full cures in a stage 1 mouse model of HAT, and a partial cure in a stage 2 mouse model of HAT. Lack of tolerability prevented delivery of a fully curative regimen in the stage 2 mouse model and thus further progress of this series.Keywords
Funding Information
- National Institute of Mental Health (HHSN-271-2008-00025-C)
- Wellcome (WT077705, WT083481)
This publication has 42 references indexed in Scilit:
- Automated design of ligands to polypharmacological profilesNature, 2012
- Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase InhibitorsJournal of Medicinal Chemistry, 2011
- Optimisation of the Anti‐Trypanosoma brucei Activity of the Opioid Agonist U50488ChemMedChem, 2011
- Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasisBiochemical Pharmacology, 2010
- N-myristoyltransferase inhibitors as new leads to treat sleeping sicknessNature, 2010
- Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike PropertiesACS Chemical Neuroscience, 2010
- Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety AttributesACS Chemical Neuroscience, 2010
- Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trialThe Lancet, 2009
- Efficient access to enantiomerically pure cyclic α-amino esters through a lipase-catalyzed kinetic resolutionTetrahedron: Asymmetry, 2008
- Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected DiseasesChemMedChem, 2008